Borroto-Esoda K - Search Results

1

Hepatitis B virus wild-type and rtN236T populations show similar early HBV DNA decline in adefovir refractory patients on a tenofovir-based regimen.

Svarovskaia ES, Curtis M, Zhu Y, Borroto-Esoda K, Miller MD, Berg T, Lavocat F, Zoulim F, Kitrinos KM. Svarovskaia ES, et al. J Viral Hepat. 2013 Feb;20(2):131-40. doi: 10.1111/j.1365-2893.2012.01638.x. Epub 2012 Jul 9. J Viral Hepat. 2013. PMID: 23301548

2

In vitro drug susceptibility analysis of hepatitis B virus clinical quasispecies populations.

Zhu Y, Curtis M, Snow-Lampart A, Yang H, Delaney W, Miller MD, Borroto-Esoda K. Zhu Y, et al. J Clin Microbiol. 2007 Oct;45(10):3335-41. doi: 10.1128/JCM.00272-07. Epub 2007 Aug 8. J Clin Microbiol. 2007. PMID: 17687019 Free PMC article.

3

Pooled analysis of amino acid changes in the HBV polymerase in patients from four major adefovir dipivoxil clinical trials.

Borroto-Esoda K, Miller MD, Arterburn S. Borroto-Esoda K, et al. J Hepatol. 2007 Oct;47(4):492-8. doi: 10.1016/j.jhep.2007.06.011. Epub 2007 Jul 23. J Hepatol. 2007. PMID: 17692425

4

Hepatitis B virus containing the I233V mutation in the polymerase reverse-transcriptase domain remains sensitive to inhibition by adefovir.

Curtis M, Zhu Y, Borroto-Esoda K. Curtis M, et al. J Infect Dis. 2007 Nov 15;196(10):1483-6. doi: 10.1086/522521. Epub 2007 Oct 31. J Infect Dis. 2007. PMID: 18008227

5

Anti-hepatitis B virus activity in vitro of combinations of tenofovir with nucleoside/nucleotide analogues.

Zhu Y, Curtis M, Qi X, Miller MD, Borroto-Esoda K. Zhu Y, et al. Antivir Chem Chemother. 2009;19(4):165-76. doi: 10.1177/095632020901900404. Antivir Chem Chemother. 2009. PMID: 19374144 Free article.

6

No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus.

Snow-Lampart A, Chappell B, Curtis M, Zhu Y, Myrick F, Schawalder J, Kitrinos K, Svarovskaia ES, Miller MD, Sorbel J, Heathcote J, Marcellin P, Borroto-Esoda K. Snow-Lampart A, et al. Hepatology. 2011 Mar;53(3):763-73. doi: 10.1002/hep.24078. Epub 2010 Dec 22. Hepatology. 2011. PMID: 21374657 Clinical Trial.

7

HBV DNA replication mediated by cloned patient HBV reverse transcriptase genes from HBV genotypes A-H and its use in antiviral phenotyping assays.

Zhu Y, Curtis M, Borroto-Esoda K. Zhu Y, et al. J Virol Methods. 2011 May;173(2):340-6. doi: 10.1016/j.jviromet.2011.03.006. Epub 2011 Mar 17. J Virol Methods. 2011. PMID: 21396961

8

The YMDD and rtA194T mutations result in decreased replication capacity in wild-type HBV as well as in HBV with precore and basal core promoter mutations.

Zhu Y, Curtis M, Borroto-Esoda K. Zhu Y, et al. Antivir Chem Chemother. 2011 Aug 23;22(1):13-22. doi: 10.3851/IMP1791. Antivir Chem Chemother. 2011. PMID: 21860069 Free article.

9

In vitro evaluation of the anti-HIV activity and metabolic interactions of tenofovir and emtricitabine.

Borroto-Esoda K, Vela JE, Myrick F, Ray AS, Miller MD. Borroto-Esoda K, et al. Antivir Ther. 2006;11(3):377-84. Antivir Ther. 2006. PMID: 16759055

10

MultiCode-RTx real-time PCR system for detection of subpopulations of K65R human immunodeficiency virus type 1 reverse transcriptase mutant viruses in clinical samples.

Svarovskaia ES, Moser MJ, Bae AS, Prudent JR, Miller MD, Borroto-Esoda K. Svarovskaia ES, et al. J Clin Microbiol. 2006 Nov;44(11):4237-41. doi: 10.1128/JCM.01512-06. Epub 2006 Sep 27. J Clin Microbiol. 2006. PMID: 17005757 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters